BlackRock Capital Allocation Term Trust (NYSE:BCAT) Reaches New 12-Month High – Here’s What Happened

BlackRock Capital Allocation Term Trust (NYSE:BCATGet Free Report) shares hit a new 52-week high on Friday . The stock traded as high as $15.98 and last traded at $15.9650, with a volume of 665279 shares. The stock had previously closed at $15.96.

BlackRock Capital Allocation Term Trust Price Performance

The firm’s 50 day moving average price is $15.27 and its two-hundred day moving average price is $14.83.

BlackRock Capital Allocation Term Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be issued a $0.2542 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) annualized dividend and a yield of 19.0%.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Large investors have recently made changes to their positions in the stock. Keener Financial Planning LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at about $29,000. Geneos Wealth Management Inc. grew its stake in BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after acquiring an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC grew its stake in BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after acquiring an additional 1,200 shares in the last quarter. McIlrath & Eck LLC increased its holdings in BlackRock Capital Allocation Term Trust by 169.6% during the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock worth $44,000 after acquiring an additional 1,969 shares during the period. Finally, Parallel Advisors LLC purchased a new stake in BlackRock Capital Allocation Term Trust in the 3rd quarter worth approximately $47,000. 36.12% of the stock is owned by institutional investors.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

Read More

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.